October 11, 2022
Estimated Release Date: November 21, 2022
Application Receipt Date: February 9, 2023
PAR-21-237 - NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke (NINDS)
The National Institute of Neurological Disorders and Stroke intends to publish a Notice of Special Interest for applications proposing qualifying clinical trials to study epidural stimulation in spinal cord injury. This notice is only for applications submitted to PAR-21-237 NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) Funding Opportunity Announcement.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
Release Date: | October 11, 2022 |
Estimated Publication Date of Notice of Special Interest (NOSI): |
November 15, 2022 |
First Estimated Application Due Date: |
February 9, 2023 |
Earliest Estimated Award Date: |
November 2023 |
Earliest Estimated Start Date: |
December 2023 |
Funding Information:
See PAR-21-237 for Funding Information.
Eligible Organizations:
See PAR-21-237 for Eligible Organizations.
Linda Bambrick, Ph.D.
National Institute of Neurological Disorders and Stroke
Telephone: 301-496-1447
Email: linda.bambrick@nih.gov